WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1999040939) METHOD FOR THE PREVENTION AND TREATMENT OF A TYPE I HYPERSENSITIVITY DISORDER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1999/040939    International Application No.:    PCT/CA1999/000109
Publication Date: 19.08.1999 International Filing Date: 09.02.1999
Chapter 2 Demand Filed:    07.09.1999    
IPC:
A61K 38/00 (2006.01), A61K 39/395 (2006.01), C07K 16/34 (2006.01)
Applicants: CANGENE CORPORATION [CA/CA]; 26 Henlow Bay, Winnipeg, Manitoba R3Y 1G4 (CA) (For All Designated States Except US).
WOLOSKI, Barry, Michael, Ronald [CA/CA]; (CA) (For US Only)
Inventors: WOLOSKI, Barry, Michael, Ronald; (CA)
Agent: RUDOLPH, John, R.; Bereskin & Parr, 40th floor, 40 King Street West, Toronto, Ontario M5H 3Y2 (CA)
Priority Data:
60/074,269 10.02.1998 US
60/092,528 13.07.1998 US
Title (EN) METHOD FOR THE PREVENTION AND TREATMENT OF A TYPE I HYPERSENSITIVITY DISORDER
(FR) PROCEDE DE PREVENTION ET DE TRAITEMENT D'UN TROUBLE D'HYPERSENSIBILITE DE TYPE 1
Abstract: front page image
(EN)Administration of Rh antibodies to an animal is effective for reducing the intensity, duration or frequency of asthmatic exacerbations, and of other type-I hypersensitivity disorders. Compositions thereof are claimed and so are their uses to prevent such disorders. Treatment with Rh antibodies in said mammal can also reduce the dosage of concomitant or other medications required by the animal for the control of this illness.
(FR)L'administration d'anticorps Rh à un animal, est efficace pour la réduction de l'intensité, la durée ou la fréquence d'exacerbations asthmatiques et d'autres troubles d'hypersensibilité de type I. L'invention porte sur les compositions desdits anticorps et leurs utilisation pour prévenir ces troubles. Le traitement aux anticorps Rh desdits mammifères, peut également permettre de réduire le dosage de médicaments concomitants ou autres, nécessaires à l'animal pour la lutte contre cette maladie.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)